They concluded more research was needed to determine the safety of these drugs, particularly after the FDA approved semaglutides as a weight loss medication for diabetic and non-diabetic patients
This helps them keep other health problems, like gallbladder problems and kidney failure risks, from getting worse
Semaglutide was developed as a drug for patients with diabetes but in the SELECT trial we demonstrated that it produced a benefit on cardiovascular disease in patients with prior heart disease, but no diabetes, Deanfield responded when asked why his research team decided to take their 2023 findings further to see what role weight loss played in heart disease prevention
Elevated bilirubin with otherwise normal liver enzymes is a red flag for UGT1A1 dysfunction (Gilbert syndrome)
It gives your brains hunger centers time to adjust to new signaling patterns
The metabolism of drugs in some cases may lead to the bioactivation of toxic compounds or the conversion of prodrugs to an active drug